Clinical Trial Update: Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Conjugate Vaccine When Co-administered With Routine Vaccines in Healthy Infants and Toddlers [Phase 3]

View source ↗

Summary

Phase 3 trial update on immunogenicity and safety of GSK meningococcal conjugate vaccine when co-administered with routine vaccines in healthy infants and toddl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Infection

Drugs mentioned

• Meningococcal Conjugate Vaccine (GSK)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Meningococcal Infection | Phase 3 | Status: COMPLETED | Results posted: 2019-08-06